• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Elevara Medicines

To add a bio or update company history, please click update information.

News from Elevara Medicines

    Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritisElevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis
    Elevara Medicines
    22 Oct 2025

    Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis

    Elevara develops oral therapies for rheumatoid arthritis by targeting synovial fibroblasts rather than the immune system, aiming to improve remission rates in chronic inflammatory disease.

Elevara Medicines
  • Life Sciences
  • London, United Kingdom
  • £50m
  • elevara.com
  • Update Information

More venture news

  • Apoha unlocks £27m in funding led by Singular to measure how molecules and materials behave under real-world conditions
    Apoha
    3 Jun 2026

    Apoha unlocks £27m in funding led by Singular to measure how molecules and materials behave under real-world conditions

    EquityLife Sciences
  •  IMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis
    IMU Biosciences
    2 Jun 2026

    IMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis

    Series ALife Sciences
  • Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform
    Perceptic
    28 May 2026

    Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn